Oslo, 22 August 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces its…
Christian Brander, Ph.D., is a leading expert on T cell responses to viral infections and brings an important blend of…
❝The commendable efforts of Dr. Lyudmila Sarder and Dr. Sarfraz Ahmad in combating the financial barriers associated with cancer treatment…
Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and researchSAN FRANCISCO--(BUSINESS WIRE)--PicnicHealth, a patient-centered…
LGR5 is expressed, both in vitro and in vivo, by numerous human cancers, including colorectal, ovarian, gastric, brain, and pancreatic…
Phase 1/2 Clinical Trial of TNX-801 for the Prevention of Mpox and Smallpox to Commence Following Submission of an IND…
– Cabozantinib in combination with atezolizumab demonstrated a statistically significant reduction in the risk of disease progression or death compared…
— Randomized, double-blind, controlled trial met primary endpoint of durable response rate and all secondary endpoints — — Overall safety consistent…
LAS VEGAS, NV / ACCESSWIRE / August 21, 2023 / Cancer Partners of Nebraska, a leading healthcare provider specializing in…
Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA…